Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome analysis reveals molecular signature and cell-type difference of Homo sapiens endothelial-to-mesenchymal transition. | G3 (Bethesda) | 2023 | 37857450 | PubTator, text mining | PubMed |
| Global transcriptomic analysis of breast cancer and normal mammary epithelial cells infected with Borrelia burgdorferi. | Eur J Microbiol Immunol (Bp) | 2023 | 37856211 | PubTator, text mining | PubMed |
| MicroRNA‑27a‑3p regulates the proliferation and chemotaxis of pulmonary macrophages in non‑small cell lung carcinoma tissues through CXCL2. | Oncol Lett | 2023 | 37854860 | PubTator, text mining | PubMed |
| IL-17 in osteoarthritis: A narrative review. | Open Life Sci | 2023 | 37854319 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics. | Cell Rep Med | 2023 | 37852187 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma Subtyping and Prognostic Model Construction Based on Chemokine-Related Genes. | Med Princ Pract | 2023 | 37848003 | PubTator, text mining | PubMed |
| CCR4-NOT differentially controls host versus virus poly(a)-tail length and regulates HCMV infection. | EMBO Rep | 2023 | 37846490 | PubTator, text mining | PubMed |
| Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance. | Nature | 2023 | 37844613 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction-associated microbiota establishes a transmissible refractory response to anti-TNF therapy during ulcerative colitis. | Gut Microbes | 2023 | 37842919 | PubTator, text mining | PubMed |
| Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma. | Cancer Drug Resist | 2023 | 37842234 | PubTator, text mining | PubMed |
| Clinical Potential of Cellular Material Sources in the Generation of iPSC-Based Products for the Regeneration of Articular Cartilage. | Int J Mol Sci | 2023 | 37833856 | PubTator, text mining | PubMed |
EGCG inhibits the inflammation and senescence inducing properties of MDA-MB-231 triple-negative breast cancer (TNBC) cells-derived extracellular vesicles in human adipose-derived mesenchymal stem cells. | Cancer Cell Int | 2023 | 37833751 | PubTator, text mining | PubMed |
| Adoptive cell therapy in paediatric extracranial solid tumours: current approaches and future challenges. | Eur J Cancer | 2023 | 37832507 | PubTator, text mining | PubMed |
| Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. | Front Immunol | 2023 | 37822929 | PubTator, text mining | PubMed |
| Probing cerebral malaria inflammation in 3D human brain microvessels. | Cell Rep | 2023 | 37819760 | PubTator, text mining | PubMed |
| Transcriptional analysis of human peripheral blood mononuclear cells stimulated by Mycobacterium tuberculosis antigen. | Front Cell Infect Microbiol | 2023 | 37818041 | PubTator, text mining | PubMed |
| Self-recruited neutrophils trigger over-activated innate immune response and phenotypic change of cardiomyocytes in fulminant viral myocarditis. | Cell Discov | 2023 | 37816761 | PubTator, text mining | PubMed |
| Identification of biomarkers, pathways, and therapeutic targets for EGFR-TKI resistance in NSCLC. | Life Sci Alliance | 2023 | 37816585 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cell and regulatory T cell therapy in non-oncology diseases: A narrative review of studies from 2017 to 2023. | Hum Vaccin Immunother | 2023 | 37814513 | PubTator, text mining | PubMed |
| Bioinformatics Approaches to Identify the Comorbidity Complexities of <em>SARS-CoV-2</em> Infection with Crohn's Disease. | J Coll Physicians Surg Pak | 2023 | 37804012 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=19